LatchBio Raises $28M Series A to Bring a Modern Data Analysis Stack to Biologists 02 Jun 2022 Thermal
Noyo Raises $45M in Series B Financing to Accelerate the Delivery of Frictionless Employee Benefits Experiences 19 May 2022 Thermal
Concert Health Raises $42M Series B Financing to Scale Quality Behavioral Health Services Nationwide 27 Apr 2022 Thermal
The Hard Lessons We Learned — and Didn’t — From Two Years in Pandemic School 24 Feb 2022 The Washington Post
Memora Health Announces $40M Financing To Scale Platform for Simplifying Complex Care Delivery 15 Feb 2022 Thermal
These gene-editing startups are aiming to solve one of CRISPR’s biggest problems. Here’s how they could upend biotech in 2022. 28 Dec 2021 Business Insider
How To Maximize Non-Emergency Medical Transportation’s Potential To Address Social Determinants Of Health 26 Oct 2021 Forbes
Andreessen Horowitz Leads $22M in Funding for Thyme Care to Improve Patient Outcomes, Close Gaps in Health Disparities, and Drive Value-Based Cancer Care 05 Oct 2021 Thermal
Meet the 30 young leaders forging a new future for the healthcare industry in 2021 16 Aug 2021 Business Insider
Meet the 12 biotechs pioneering cutting-edge cures that stand to upend how we treat diseases and transform pharma 05 Aug 2021 Business Insider
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome 09 Jun 2021 Thermal
Concert Health Inks Two More Collaborative Care Partnerships, Continues Aggressive Growth 03 Jun 2021 Behavioral Health Business
A View From The Top: Six Healthcare Execs On How To Close The Nation’s Mental Health Care Gap 27 May 2021 Forbes
Herophilus Appoints Sharath Hegde, Ph.D. as Chief Scientific Officer as it Scales Drug Discovery Effort for Complex Brain Diseases 27 May 2021 Thermal
Tory Burch and Nobel Prize winner Jennifer Doudna are teaming up to help women scientists 20 May 2021 Fast Company
Q Bio unveils ‘digital twin’ whole-body imaging platform, with Kaiser Permanente backing 30 Apr 2021 FierceBiotech
Doudna’s Scribe Rewrites CRISPR Drug Development with $100 Million Series B 31 Mar 2021 Genetic Engineering and Biotechnology News
Scribe, Jennifer Doudna’s newest startup, nabs a mega-round and a vocal investor 31 Mar 2021 Endpoints News
Jennifer Doudna on the Pandemic Year: The Power of Mission-Driven Science 18 Mar 2021 The Wall St. Journal
“The Code Breaker”: Jennifer Doudna and how CRISPR may revolutionize mankind 07 Mar 2021 CBS Sunday Morning
Nobel laureates Frances Arnold and Jennifer Doudna on prizes, pandemics, and Jimmy Page 16 Feb 2021 Chemical and Engineering News
Concert Health Completes $14M Series A Financing to Deliver Evidence-based Behavioral Health Services at Scale 28 Jan 2021 Thermal
Why Jennifer Doudna’s DNA discovery is revolutionising the way we tackle disease 03 Jan 2021 The Times